World Psoriasis Day Challenge Launched by Psoriasis Cure Now

Oct. 3, 2010 - PRLog -- As World Psoriasis Day approaches on October 29, 2010, the US-based NGO Psoriasis Cure Now is challenging psoriasis patients worldwide to take its World Psoriasis Day Challenge to make the day about increasing worldwide research funding for psoriasis and psoriatic arthritis. The campaign is on the web here: http://www.psoriasis-cure-now.org/worldpsoriasisdaychallenge/ .

"The number one priority for psoriasis patients worldwide should be to increase research funding for psoriasis and psoriatic arthritis," said Michael Paranzino, president of Psoriasis Cure Now. "Leveraging the power of all the world's governments and people toward that end could dramatically speed the development of a cure."

Currently, the United States leads the world in biomedical research funding for all diseases, including for psoriasis. Last year, the U.S. government invested more than $30 billion in medical research funding, or about 76 Euro per American citizen. That's about triple what the next leading nations spent, Canada and the U.K., which spent about 23 Euro per citizen of their countries. The $16 million in U.S. taxpayer funds spent last year on psoriasis research is also believed to be a world record.

"Too many wealthy nations are not carrying their weight in supporting vital medical research that will help scientists unlock new treatments and cures for psoriasis and other serious diseases," added Paranzino. "Psoriasis patients worldwide should lead the charge for increasing these investments in research."

At Psoriasis Cure Now's World Psoriasis Day Challenge website, people can learn strategies to help increase research funding in their countries, and even see which wealthy nations are spending just 10% of what the USA spends per citizen on medical research funding.  For more information, visit http://www.psoriasis-cure-now.org/worldpsoriasisdaychalle... .

# # #

Nonprofit patient advocacy organization working to increase research funding for psoriasis and psoriatic arthritis, while educating patients and the public about this serious but noncontagious immune system disease.